Sun Pharma’s Psoriasis Drug Shows Promise for Treating Joint Disease in Major Clinical Trials
July 21, 2025 – Sun Pharmaceutical Industries, India’s largest drug maker, announced today that its psoriasis medication ILUMYA has successfully completed two major clinical trials for treating psoriatic arthritis, a painful joint condition that affects millions worldwide. The positive results from the INSPIRE-1 and INSPIRE-2 studies represent a significant milestone that could lead to expanded […]